Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effects of Alternating Altitude Training Versus Fixed-Altitude Training on Exercise Capacity and Physiological Adaptations in Elite Race Walkers: A Randomized Controlled Trial

16 de julho de 2026 atualizado por: Chaoran Han, Macao Polytechnic University

Effects of Alternating Altitude Training Versus Fixed-Altitude Training on Physical Performance and Physiological Adaptations in Elite Race Walkers: A Randomized Controlled Trial

This randomized controlled trial aims to compare the effects of alternating altitude training and fixed-altitude training on physical performance and physiological adaptations in elite race walkers living at altitude. Elite race walkers from Yunnan Province will be randomly assigned to either an alternating altitude training group or a fixed-altitude training group. The alternating altitude training group will perform selected training sessions under simulated higher-altitude conditions while completing the remaining sessions at their regular altitude training base. The fixed-altitude training group will complete all training sessions at the regular altitude. Physical performance, race walking performance, cardiovascular function, pulmonary function, and hematological parameters will be assessed before and after the intervention to evaluate the effectiveness of the two altitude training strategies.

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

16

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

  • China
      • Macao, China
        • Recrutamento
        • Macao Polytechnic University, Faculty of Health Sciences and Sports, Macao, China
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  • Male and female elite race walkers aged 16-26 years. Registered athletes from the Yunnan Provincial Race Walking Team. Long-term residents of high-altitude regions with regular altitude training experience.

Healthy and medically cleared to participate in high-intensity training and hypoxic exposure.

Able to complete the prescribed training program and all outcome assessments. Provided written informed consent before enrollment. For participants younger than 18 years, written informed consent will also be obtained from a parent or legal guardian.

Exclusion Criteria:

  • Any cardiovascular, respiratory, metabolic, neurological, or other medical condition contraindicating exercise or hypoxic exposure.

Musculoskeletal injury or illness affecting normal training or performance within the previous three months.

Current use of medications or supplements that may substantially influence physiological adaptation or exercise performance.

Failure to complete the intervention or outcome assessments according to the study protocol.

Withdrawal of informed consent at any time during the study.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Alternating Altitude Training
Participants perform the prescribed training program using an alternating altitude strategy, with selected training sessions conducted under simulated higher-altitude conditions and the remaining sessions completed at the regular altitude training base.
Comportamental: Alternating Altitude Training
Participants complete the prescribed training program using an alternating altitude strategy, combining regular altitude training with selected sessions performed under simulated higher-altitude conditions.
Comparador Ativo: Fixed-Altitude Training
Participants perform the same prescribed training program entirely at the regular altitude training base throughout the intervention.
Comportamental: Fixed-Altitude Training
Participants complete the prescribed training program exclusively at the regular altitude training base.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Body Weight
Prazo: Baseline and immediately after completion of the 4-week intervention.
Body weight measured before and after the training period.
Baseline and immediately after completion of the 4-week intervention.
Body Fat Percentage
Prazo: Baseline and immediately after completion of the 4-week intervention.
Body fat percentage measured using bioelectrical impedance or other validated method.
Baseline and immediately after completion of the 4-week intervention.
Forced Vital Capacity (FVC)
Prazo: Baseline and immediately after completion of the 4-week intervention.
Forced vital capacity measured using spirometry before and after the intervention.
Baseline and immediately after completion of the 4-week intervention.
Maximal Voluntary Ventilation
Prazo: Baseline and immediately after completion of the 4-week intervention.
MVV measured using standard pulmonary function testing protocol pre- and post-intervention.
Baseline and immediately after completion of the 4-week intervention.
Left Ventricular Volume
Prazo: Baseline and immediately after completion of the 4-week intervention.
Echocardiography measurement of left ventricular end-diastolic and end-systolic volume.
Baseline and immediately after completion of the 4-week intervention.
Ejection Fraction
Prazo: Baseline and immediately after completion of the 4-week intervention.
Echocardiography assessment of left ventricular ejection fraction pre- and post-training.
Baseline and immediately after completion of the 4-week intervention.
Myocardial Thickness
Prazo: Baseline and immediately after completion of the 4-week intervention.
Measurement of interventricular septum and left ventricular posterior wall thickness by echocardiography.
Baseline and immediately after completion of the 4-week intervention.
Maximal Oxygen Uptake
Prazo: Baseline and immediately after completion of the 4-week intervention.
Pre- and post-intervention measurement of VO₂max using standard exercise testing protocol to assess aerobic capacity
Baseline and immediately after completion of the 4-week intervention.
Countermovement Jump Height
Prazo: Baseline and immediately after completion of the 4-week intervention.
Countermovement jump (CMJ) height measured using a validated force platform or jump assessment system to evaluate lower-limb explosive power before and after the intervention.
Baseline and immediately after completion of the 4-week intervention.
Squat Jump Height
Prazo: Baseline and immediately after completion of the 4-week intervention.
Squat jump (SJ) height measured using a validated force platform or jump assessment system to assess concentric lower-limb explosive strength before and after the intervention.
Baseline and immediately after completion of the 4-week intervention.
Isometric Mid-Thigh Pull Peak Force
Prazo: Baseline and immediately after completion of the 4-week intervention.
Peak force during the isometric mid-thigh pull (IMTP) measured using a force platform to assess maximal isometric lower-limb strength before and after the intervention.
Baseline and immediately after completion of the 4-week intervention.
Isometric Mid-Thigh Pull Rate of Force Development
Prazo: Baseline and immediately after completion of the 4-week intervention.
Rate of force development (RFD) during the isometric mid-thigh pull (IMTP) measured using a force platform before and after the intervention.
Baseline and immediately after completion of the 4-week intervention.
Reactive Strength Index (RSI)
Prazo: Baseline and immediately after completion of the 4-week intervention.
Reactive Strength Index (RSI) calculated from repeated ankle hops using a force platform or validated jump assessment system to assess lower-limb reactive strength before and after the intervention.
Baseline and immediately after completion of the 4-week intervention.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Red Blood Cell Count
Prazo: Baseline and immediately after completion of the 4-week intervention.
RBC count measured from venous blood samples pre- and post-intervention.
Baseline and immediately after completion of the 4-week intervention.
Hemoglobin
Prazo: Baseline and immediately after completion of the 4-week intervention.
Hemoglobin concentration measured from venous blood samples.
Baseline and immediately after completion of the 4-week intervention.
Hematocrit
Prazo: Baseline and immediately after completion of the 4-week intervention.
Hemoglobin concentration measured from venous blood samples.
Baseline and immediately after completion of the 4-week intervention.
Erythropoietin
Prazo: Baseline and immediately after completion of the 4-week intervention.
Plasma EPO concentration measured from venous blood samples.
Baseline and immediately after completion of the 4-week intervention.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Macao Polytechnic University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

20 de julho de 2026

Conclusão Primária (Estimado)

5 de setembro de 2026

Conclusão do estudo (Estimado)

5 de setembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

14 de julho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de julho de 2026

Primeira postagem (Real)

21 de julho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

21 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de julho de 2026

Última verificação

1 de julho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • AAT-RW-2026-01

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Altitude Training

Ensaios clínicos em Alternating Altitude Training

Pesquisar ensaios semelhantes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

CROs by country

CROs in Bulgaria

Condições

Doenças Raras

Intervenções de drogas

Suplementos Alimentares

Patrocinador / Colaboradores

Localizações

Se inscrever